LENZ Therapeutics, Inc. (LENZ)

LENZ Therapeutics Market Cap

LENZ Therapeutics has a market cap or net worth of $390.41 million as of May 31, 2024. Its market cap has increased by 130.06% in one year.

• Market Cap: 390.41M
• Enterprise Value: 177.17M
• 1-Year Change: 130.06%
• Ranking: #3145
• Category: Small-Cap
• Stock Price: $15.29

Market Cap Chart

Since the IPO on June 25, 2021, LENZ Therapeutics's market cap has decreased from $951.31M to $390.41M, a decrease of -58.96%. That is a compound annual growth rate of -26.20%.

Market Cap History

Date	Market Cap	% Change
May 30, 2024	396.00M	0.13%
May 29, 2024	395.50M	0.64%
May 28, 2024	393.00M	-1.97%
May 24, 2024	400.90M	-0.12%
May 23, 2024	401.40M	-14.61%
May 22, 2024	470.10M	-1.24%
May 21, 2024	476.00M	0.27%
May 20, 2024	474.70M	13.70%
May 17, 2024	417.50M	-1.09%
May 16, 2024	422.10M	4.35%
May 15, 2024	404.50M	0.77%
May 14, 2024	401.40M	-1.21%
May 13, 2024	406.30M	1.15%
May 10, 2024	401.70M	2.16%
May 9, 2024	393.20M	-4.82%
May 8, 2024	413.10M	202.19%
May 7, 2024	136.70M	1.56%
May 6, 2024	134.60M	-1.68%
May 3, 2024	136.90M	0.29%
May 2, 2024	136.50M	3.80%
May 1, 2024	131.50M	-0.38%
Apr 30, 2024	132.00M	-3.86%
Apr 29, 2024	137.30M	4.97%
Apr 26, 2024	130.80M	1.79%
Apr 25, 2024	128.50M	-2.58%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
Cibus	416.34M
Acelyrin	404.03M
Theravance Biopharma	403.17M
ModivCare	402.31M
Verve Therapeutics	399.03M
Contineum Therapeutics	394.85M
Biomea Fusion	391.44M
Fate Therapeutics	390.44M